Fig. 2.

(A) Swimmer plot showing N = 20 COVID-19 positive head and neck cancer patients (y-axis indicates their current or prior cancer treatment while an asterisk indicates they received treatment <30 days from COVID-19 diagnosis) hospitalized and/or requiring intensive care unit (ICU) care organized by length of stay (in days). To the left is a color grid with tiles showing key clinical and disease characteristics (grey: former or current smoker, red: recurrent/metastatic disease, pink: curative intent disease, blue: tracheostomy or laryngectomy stoma, green: PEG in place, black: at a long-term care [LTC] facility at the time of admission). CRT = chemoradiation, S = surgery, R = radiotherapy, I = induction chemotherapy, IO = immunotherapy, C = chemotherapy. (B) Bar graph showing the number of patients receiving COVID-19 therapies during admission to hospital floor vs. the ICU. HCQ = hydroxychloroquine. (C) Box and whisker plot showing peak median inflammatory markers for hospitalized patients with COVID-19 separated by hospital floor and ICU stay (*) p < 0.05, Mann-Whitney U test, two-sided. Normal reference ranges: ESR (0–20 mm/h), CRP (0–10 mg/L), D-dimer (<500 ng/dL), ferritin (30–400 ug/L). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)